Severe hypertension related to caffeinated coffee and tranylcypromine: A case report

Annals of Internal Medicine

Volumn 160, Issue 9, 2014, Pages 657-658

  Van Der Hoeven, Niels ^a   Visser, Ieke ^a   Schene, Aart ^b   Van Den Born, Bert Jan ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; HYDROCHLOROTHIAZIDE; TRANYLCYPROMINE;

ADULT; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG INDUCED HEADACHE; EVALUATION STUDY; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; LETTER; MAJOR DEPRESSION; MALE; MIDDLE AGED; PRIORITY JOURNAL;

CAFFEINE; COFFEE; DEPRESSIVE DISORDER, MAJOR; DRUG INTERACTIONS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; TRANYLCYPROMINE;

EID: 84900425803     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/L14-5009-8     Document Type: Letter

References (4)

1. Flockhart DA. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update. J Clin Psychiatry. 2012;73 Suppl 1:17-24. [PMID: 22951238]
2. Horwitz D, Lovenberg W, Engelman K, Sjoerdsma A. Monoamine oxidase inhibitors, tyramine, and cheese. JAMA. 1964;188:1108-10. [PMID: 14163106]
3. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51:83-133. [PMID: 10049999]
4. Herraiz T, Chaparro C. Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee. Life Sci. 2006;78: 795-802. [PMID: 16139309]